https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Validation of a Flow Cytometry Live Cell-Based Assay to Detect Myelin Oligodendrocyte Glycoprotein Antibodies for Clinical Diagnostics https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46794 Wed 30 Nov 2022 14:31:28 AEDT ]]> Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:45703 Wed 24 Jan 2024 14:33:03 AEDT ]]> Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:48348 Wed 14 Feb 2024 15:59:55 AEDT ]]> Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 2 New and emerging therapies and their efficacy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18887 Sat 24 Mar 2018 08:03:12 AEDT ]]> Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 3 Treatment practicalities and recommendations https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18888 Sat 24 Mar 2018 08:03:11 AEDT ]]> Therapeutic approaches to disease modifying therapy for multiple sclerosis in adults: An Australian and New Zealand perspective Part 1 Historical and established therapies https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:18886 Sat 24 Mar 2018 08:03:11 AEDT ]]> A new era in the treatment of multiple sclerosis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:23863 Sat 24 Mar 2018 07:12:10 AEDT ]]>